Why Contraceptive Innovation?

Despite the availability of various contraceptive methods, more than 200 million women in developing countries want to avoid or delay pregnancy yet are not using an effective family planning method. For some of these women, access to contraception is limited. For others, currently available methods do not meet their needs or preferences or are unaffordable. Innovative solutions are needed in the areas of product development, registration, pricing, and introduction to address these barriers.

Join the exchange and become part of the solution!

Visit our resource library for additional information about the need for contraceptive innovation.


Resources

A one-stop shop for resources related to contraceptive research and development

The CTI Exchange offers resources about contraceptive research and development, including information about products currently in development, preclinical and clinical research, and opportunities for future investment. This easily searchable resource library also includes information about regulatory requirements, quality assurance standards, intellectual property, and product introduction strategies, as well as tools for advocacy.

View all resources


Updates

Latest news, events, resources, and thought pieces from the Exchange's blog

blog

Why Women-Centered MPT Development Matters
Social, behavioral, and gender influences that shape women’s and girls’ ability to use MPT products are key both early, in product design, and later, in product introduction efforts.
commentary

High-Tech Fertility Awareness: Moving Beyond the Beads
Fertility apps designed to prevent or plan pregnancy are attractive to women because they are free of side effects, help them understand their fertility, and can be accessed entirely through...
commentary

Introducing Sayana Press into Senegal Method Mix
Introducing Sayana Press in Senegal meant encouraging the population to accept the product, ensuring its availability within health facilities, and promoting its effective distribution by he...
commentary

A Fresh Start to Female Condom Marketing
The introduction of the Woman's Condom, coupled with targeted marketing and education, will lead to increased interest in trying female condom products and more protected sex.
blog

Daré Bioscience & Orbis Biosciences to Collaborate on Injectable...
Daré Bioscience and Orbis Biosciences will collaborate on development of two etonogestrel-based, longer-acting injectable contraceptives.
commentary

Male Contraceptives in the Pipeline
There are many potential targets and methods for male contraception, with several products in the research and development pipeline showing exceptional promise.
commentary

Refining Well-Established Contraceptive Methods
While injectables have been around for 50 years, the truth is no contraceptive technology advancement should be viewed as one and done.
blog

Male Contraception Initiative Awards Four Research Grants
The Male Contraception Initiative (MCI) will fund four research teams working to develop a new reversible non-hormonal birth control pill for men.
commentary

Why Male Contraception?
Researchers are beginning to focus on affecting sperm function rather than halting sperm production, including preventing sperm from swimming or being able to fertilize an egg,
commentary

Biodegradable Implants: A Novel Idea Revisited
Because of its dissolving/reabsorbing characteristics, a biodegradable contraceptive implant would be unlike any method currently available.
news

Contraceptive Research Opportunity for Small Businesses
NICHD has issued a Small Business Innovation Research funding solicitation to support/facilitate development of new or improved contraceptive products for men and women. 
news

Key Conference Abstract Deadlines Approaching
Calls for abstracts and panels have been announced for three upcoming conferences of interest to contraceptive researchers.

Featured Resources

Other key resources related to contraceptive research and development

Calliope, the Contraceptive Pipeline Database, includes information on potential contraceptive targets and leads, products in development, and a selection of products only available in limited markets.
CAPRI, the Contraceptive Active Pharmaceutical Ingredient Database, lists biological and chemical properties for 27 active pharmaceutical ingredients found in contraceptives, along with data on their pharmacology, toxicology, impurities, metabolites, and use in marketed products.

Contribute

We want you to join the exchange!

The CTI Exchange looks to partners to help generate and share resources. Contact us with your ideas, materials, or questions, or sign up to receive more information. We also encourage you to provide your feedback